type here...

News

Covid-19

Regulators Should Keep a Close Eye on the Little Guys in the Race for a Covid-19 Vaccine

Jérôme Adda
As the race to find a Covid-19 vaccine or treatment rages on, many have raised concerns over trustworthiness of clinical research and questioned whether...
What we are reading

Facebook to Ban Ads Discouraging Vaccines

ProMarket writers
What we are reading

Robert Lighthizer Blew Up 60 Years of Trade Policy. Nobody Knows What Happens Next.

ProMarket writers
Commentary

Friedman’s Legacy: From Doctrine to Theorem

Luigi Zingales
Friedman was more right than his detractors claim and more wrong than his supporters would like us to believe. However, after 50 years of...
What we are reading

Pandemic Will Cause ‘Lasting Damage’ to Living Standards, IMF Warns

ProMarket writers
What we are reading

Covid-19 Vaccines Are Chance at Salvation, Financial and Beyond, for Drug Makers

ProMarket writers
Antitrust and Competition

Government Regulation is the Pro-Market Solution

Steven K. Vogel
The Covid-19 pandemic has utterly discredited the false dichotomy of government vs. markets. Extensive government regulation is a prerequisite for the proper functioning of...
What we are reading

Mark Zuckerberg is Spending Millions Like Never Before to Overhaul a Landmark Law

ProMarket writers
What we are reading

Charles Koch’s Big Bet on Barrett

ProMarket writers
What we are reading

‘Too Complex to Break Up’ Is the New ‘Too Big to Fail’

ProMarket writers
1...316317318...395Page 317 of 395

Latest news

View All

The publication of the Stigler Center at The University of Chicago Booth School of Business

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.